The Pre-clinical imaging market report provides qualitative insights about the key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders.
Complete 84 market data tables & 65 figures spread through 184 pages and in-depth TOC on "Pre-Clinical Imaging (In-VIVO) Market " at www.reportsnreports.com/reports/20…asts-to-2017.html .
In report, pre clinical imaging market has been segmented on the basis of modality(covering optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photo acoustic, and magnetic particle imaging systems), by type of reagents (including nuclear imaging reagents, optical imaging reagents, MRI contrast agents, ultrasound contrast agents and CT contrast agents), and by region (North America, Europe, Asia Pacific, and Rest of the World).
- Preclinical Imaging Instrument Manufacturers, Suppliers, and Imaging Software Providers
- Pharmaceutical and Biotechnology Companies
- Preclinical Imaging Reagent Manufacturers and Suppliers
- Contract Research Organizations (CROs)
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Medical Research Laboratories
- Academic Medical Institutes and Universities
The growth of preclinical imaging market is driven by factors like development of technologically advanced hybrid preclinical imaging systems like PET/CT, PET/MRI, and PET/SPECT/CT; growing acceptance of preclinical imaging as a legitimate drug development tool; & Rising volume of preclinical research.In addition, emerging markets offering lucrative growth and departure of major companies from preclinical imaging systems market are creating new growth opportunities for preclinical imaging systems and reagents manufacturers.
The global preclinical imaging market is segmented into two major categories, namely, modality (optical imaging systems, nuclear imaging systems, micro-MRI systems, micro-Ultrasound systems, micro-CT systems, photoacoustic imaging systems, and magnetic particle imaging systems) and reagents (optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents).
Industry Insights Covered in this research as follows
2 Value Chain Analysis
3 Supply Chain Analysis
4 Key Stakeholders
5 Key Influencers
6 Industry Trends
7 Rising Focus of Market Players Towards the Development of Hybrid Pre-Clinical Imaging Systems
8 Increasing Government Funding for Pharmaceutical Research and Development in Emerging Nations
9 Porter’s Five Forces Analysis
10 Bargaining Power of Suppliers
Geographically, North America (comprising the U.S. and Canada) commands the largest share of 36.2% of the global pre clinical imaging market in 2014, followed by Europe.
The preclinical imaging market in North America is primarily driven by various factors high volume of preclinical research in this region, easy availability and accessibility of resources (such as radioactive tracers), and rising government funding for research and innovation in Canada.
Single user licence, discount copy of “Pre Clinical Imaging (In-VIVO) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019” research report can be requested at www.reportsnreports.com/contacts/.aspx?name=208975 .
New product launches and product enhancements are the key growth strategies adopted by major players to develop their positions in the global preclinical imaging market. Moreover, strategies such as geographic expansions; and partnerships, agreements, and collaborations; acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the global preclinical imaging market.